Ramin Baghirzade, Ph.D., Global Head Commercial, Gene Therapy CDMO Services  Oct. 12 | 2:00pm | Oxford Biomedica Ballroom  Wilmington, MA  (NASDAQ: CRL)  In-person Presentation  A CRO/CDMO with 75 years experience bringing therapeutics to market. Charles River now has a concept-to-commercial portfolio in cell and gene therapy enabling partners to reduce...

  Noah Davidsohn, Ph.D., Chief Scientific Officer  Oct. 11 | 2:45pm | Oxford Biomedica Ballroom  San Diego, CA  (Private)  In-person Presentation  Rejuvenate Bio is reversing aging and eliminating age related disease. Aging is caused by a change in gene expression in the body that manifests itself in age related disease. Aging...

Sven Kili, CEO  Oct. 12 | 1:45pm | Oxford Biomedica Ballroom  Geneva, Switzerland   (Private)  In-person Presentation  Antion Biosciences is the world leader in efficient, safe and cost effective Cell Multiplexing technologies for almost any cell type. We develop cutting-edge allogeneic immuno- cell therapies in indications of high unmet...

Nina Bauer, Ph.D., Global Head of Commercial  Oct. 12 | 9:00am | Oxford Biomedica Ballroom  Burlington, MA  (OTCMKTS: MKKGY)  In-person Presentation  MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany.  From solving your unique upstream and downstream challenges, to meeting urgent manufacturing timelines, and navigating uncertain regulatory...

Patricio Sepulveda, Ph.D., CEO  Oct. 11 | 4:45pm | Oxford Biomedica Ballroom Towson, MD (Private)  In-person Presentation  Amplo Biotechnology is a late preclinical stage company developing AAV therapies to treat diseases of the neuromuscular junction, the connection between muscle and nerve.  Amplo’s lead asset, AMP-101, uses a muscle specific AAV...

Peter Francis, Chief Scientific and Medical Officer   Oct. 12 | 1:15pm | Oxford Biomedica Ballroom  San Francisco, CA  (Private)  In-person Presentation  Ray Therapeutics is a late-stage preclinical biotechnology company pioneering next generation optogenetic therapies for vision restoration to individuals with blindness. The company is based in the San Francisco Bay...

Brian Culley, CEO  Oct. 12 | 2:15pm | UBC Ballroom  Carlsbad, CA  (NASDAQ: LCTX)  In-person Presentation  Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. Lineage develops and...

Patrick Lucy, President and CEO Oct. 11 | 5:45pm | Oxford Biomedica Ballroom   Hopkinton, MA  (Private)  In-person Presentation  Lykan Bioscience is an innovative contract development and manufacturing services organization (CDMO) focused on cell-based therapies. With decades of biopharmaceutical industry experience, Lykan offers a full range of development and manufacturing services. The...

Julia Tarasenko, Senior Vice President, Global Commercial Operation, Sales, and Pricing  Oct. 12 | 10:00am | Oxford Biomedica Ballroom  Durham, NC  (Private)  In-person Presentation  Marken is a wholly owned subsidiary of UPS and is a critical part of UPS Healthcare. With Polar Speed and Marken included, the UPS Healthcare division staffs...

Jeff Vassallo, Senior Director, Clinical Operations Oct. 12 | 5:00pm | Oxford Biomedica Ballroom   Cincinnati, OH  (NASDAQ: MEDP)  In-person Presentation  Medpace is a scientifically-driven, global, full service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Medpace’s mission is to accelerate...

By using this website you agree to accept our Privacy Policy and Terms & Conditions